# The Effect of Preoperative Intravenous Ferric Derisomaltose and EPO and Tranexamic Acid in Patients With Preoperative Anemia or Iron Deficiency in Bone Tumor

> **NCT07314424** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Tang Xiaodong** · enrollment: 160 (estimated)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** isomaltose iron

## Key facts

- **NCT ID:** NCT07314424
- **Lead sponsor:** Tang Xiaodong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07314424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07314424, "The Effect of Preoperative Intravenous Ferric Derisomaltose and EPO and Tranexamic Acid in Patients With Preoperative Anemia or Iron Deficiency in Bone Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07314424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*